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Abstract
To determine the prevalence, associated factors, awareness and control of dyslipidemia in Chinese living in Greater Beijing,
we measured the serum cholesterol concentration in 3251 Chinese adults (age: 45 to 89 years) as participants of the
population-based Beijing Eye Study 2006. Additional information on treatment of dyslipidemia was obtained using a
standard questionnaire. The mean concentrations of total, HDL cholesterol, LDL cholesterol and triglycerides were
4.9261.01 mmol/L, 1.6160.36 mmol/L, 2.8860.85 mmol/L, and 1.7661.29 mmol/L, respectively. Prevalence of dyslipidemia
was 56.160.9%%. Presence of dyslipidemia was significantly associated with increasing age (odds ratio (OR):1.02; 95%
confidence interval (CI): 1.01, 1.03), female gender (OR:1.51; 95%CI: 1.25, 1.83), urban region (OR:1.82; 95%CI: 1.30, 2.55),
body mass index (OR:1.13; 95%CI: 1.10, 1.15), income (OR:1.11; 95%CI:1.02, 1.21), blood glucose concentration (OR:1.10;
95%CI:1.05, 1.16), diastolic blood pressure (OR:1.02; 95%CI: 1.01, 1.03), and smoking (OR:1.23; 1.01, 1.51). Among those who
had dyslipidemia, the proportion of subjects who were aware, treated and controlled was 50.9%, 23.8%, and 39.91%,
respectively. The awareness rate was associated with urban region (P=0.001; OR: 6.50), body mass index (P=0.001; OR:1.06),
and income (P=0.02; OR:1.14). The data suggest that dyslipidemia may be present in about 56% of the population aged 45+
years in Greater Beijing. Factors likely associated with dyslipidemia were higher age, female gender, urban region, higher
body mass index, higher income, higher blood concentration of glucose, higher diastolic blood pressure, and smoking. In
the examined study population, treatment rate was 24% with about 60% of the treated subjects still having uncontrolled
dyslipidemia.
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Introduction
Dyslipidemia, a major systemic disorder, is one of the most
important risk factors for cardiovascular diseases which are a
major cause of morbidity and a leading contributor to mortality
worldwide [1]. It also includes developing countries, and among
them in particular China [1,2]. Over the next 20 years,
cardiovascular disease morbidity and mortality in China has been
projected to increase both in absolute number and as a proportion
of total disease burden [2]. The marked increase in cardiovascular
diseases in economically developing countries has resulted from
the economic growth and associated sociodemographic changes
that have occurred over recent decades. During this period, the
burden of illness from infectious disease has fallen. Parallel changes
in lifestyle and diet have led to an increase in life expectancy and a
greatly increased burden of cardiovascular disease and other
chronic diseases [2–4]. Dyslipidemia is one of the most important
modifiable risk factors for cardiovascular diseases [5–10]. Previous
population-based studies form China [11–21], such as the Sino-
MONICA Study from 1983 to 1993 [2,11,13], the International
Collaborative Study of Cardiovascular Diseases in Asian (Inter-
ASIA) from 2000 to 2001 [15], and The Fourth Chinese National
Nutrition and Health Survey from 2002 [14], revealed that the
Chinese population as compared with Western societies previously
had lower concentrations of serum lipids and a lower prevalence of
dyslipidemia. The studies also showed a trend over the recent
decades towards an increase in the prevalence of dyslipidemia in
China, parallel to a change in the lifestyle. The changes
predominantly took place in the urban areas, while the situation
changed to a lesser degree in rural communities. There have been
only few recent studies addressing the medically and socio-
economically important question of the prevalence of dyslipidemia
and its associated factors in rural and urban areas of China. We,
therefore, assessed in our population-based investigation the
frequency of dyslipidemia, its associated factors, and the
awareness, treatment, and control of dyslipidemia in the urban
and rural region of Greater Beijing.
Results
Demographic Parameters
The study included 2951 (90.8%) subjects (1674(56.7%) women)
for whom serum lipids measurements were available. The mean
age was 60.4610.0 years (median: 60 years; range: 45–89 years).
Out of the 2951individuals, 1407(47.7%) subjects (834 women)
came from the rural region, and 1544 (52.3%) subjects
(840women) came from the urban region. The subjects from the
rural region compared with the subjects from the urban region
were significantly younger (56.969.0 years versus 63.669.9 years;
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17326P,0.001), and had a significantly lower monthly income
(3996310 Yuan versus 21776594 Yuan; P,0.001) and a lower
level of education (P,0.001). The participants of the survey 2006
compared with the non-participants were significantly younger
(55.3610.1 years versus 58.6611.6 years; P,0.001), came more
often from the rural region than from the urban region (1500/
1751 versus 473/714; P,0.001), and had a higher level of
education (P=0.001). There were no significant differences in
gender (P=0.84) and reported income (10676827 versus
109361052; P=0.41).
Laboratory Results
Mean levels of total cholesterol, HDL (high-density lipoprotein)
cholesterol, LDL (low-density lipoprotein) cholesterol, and triygl-
cerides were 4.9261.01 mmol / L, 1.6160.36 mmol/L,
2.8860.85 mmol/L, and 1.7661.29 mmol/L, respectively
(Fig. 1). A hypercholesterolemia (total cholesterol concentration
$5.72 mmol/L (220 mg/dL)) was found in 19.060.7%, a
hypertrigylceridemia (triglyceride concentration $1.70 mmol/L
(150 mg/dL)) in 35.560.9%, and abnormally low high-density
lipoprotein-cholesterol (HDL-C concentration #0.91 mmol/L
(35 mg/dL)) in 1.760.2% of the study population. Dyslipidemia
was found for 1332 (45.160.9%) subjects (95%CI: 43.3%, 46.9%).
A positive history for dyslipidemia was described by 842 (28.5%)
subjects, so that the total prevalence of dyslipidemia was 1654 /
2951 or 56.160.9% (95%CI: 54.3%, 57.8%). For all further
statistical analysis, the total prevalence of dyslipidemia (abnormal
blood examinations results and / or positive history for
dyslipidemia) was taken. Adjusted for age and gender on the
basis of Chinese census 2000, the prevalence of dyslipidemia was
54.1%.
Univariate Analysis
In univariate analysis, all four blood laboratory parameters were
significantly (P,0.001) correlated with each other. In univariate
analysis, the prevalence of dyslipidemia was significantly associated
with age, female gender, urban region, body mass index (all
P,0.001), lower body height (P=0.02), body weight (P,0.001),
level of education (P,0.001), income (P,0.001), fasting serum
concentration of glucose (P,0.001), systolic blood pressure
(P=0.02), mean arterial blood pressure (P=0.03), and less
consumption of wine (P=0.001) and less smoking (P=0.002)
(Table 1). The prevalence of dyslipidemia was not significantly
associated with consumption of beer (P=0.79).
Multivariate Analysis
In a binary multivariate logistic regression analysis, with the
presence of dyslipidemia as dependent variable and all parameters,
Figure 1. Boxplots showing the distribution of total cholesterol, triglycerides, high-density lipoprotein cholesterol and low-density
lipoprotein cholesterol in the Beijing eye Study.
doi:10.1371/journal.pone.0017326.g001
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analysis, as independent variables, revealed that the presence of
dyslipidemia was still significantly associated with increasing age
(P,0.001), female gender (P,0.001), urban region (P=0.001),
body mass index (P,0.001), income (P=0.01), blood concentra-
tion of glucose (P,0.001), diastolic blood pressure (P=0.02), and
smoking (P=0.04) (Table 1). In the binary logistic regression
analysis with adjustment for age, gender, urban versus rural
region, body mass index, income, blood glucose concentration,
diastolic blood pressure and smoking, the prevalence of dyslipi-
demia was no longer associated with level of education (P=0.40),
systolic blood pressure (P=0.56) and consumption of wine
(P=0.24).
Awareness of Dyslipidemia
Out of the 2951 study participants, 842 (28.5%) subjects
(28.5%60.8%; 95%CI: 26.9%, 30.2%) or 842 subjects out of the
1654 subjects with dyslipidemia (50.9%61.2%; 95%CI: 48.5%,
53.3%) reported of any previous diagnosis of dyslipidemia by a
healthcare professional. Within the group of subjects with
dyslipidemia, the prevalence of the awareness of dyslipidemia
was significantly associated (univariate analysis) with increasing
age (P,0.001), male gender (P=0.001), urban region (P,0.001),
lower body mass index (P=0.001), higher income (P,0.001),
lower blood concentration of glucose (P=0.02), lower diastolic
blood pressure (P,0.001), and less smoking (P,0.001) (Table 2).
In a multivariate binary logistic regression analysis, with the
presence of awareness of dyslipidemia as dependent variable and
all parameters, which were significantly associated with dyslipide-
mia in univariate analysis, as independent variables, revealed that
the presence of dyslipidemia was still significantly associated with
urban region (P=0.001), body mass index (P=0.001), and higher
income (P=0.02), while it was no longer significantly associated
with age (P=0.56), gender (P=0.21), blood concentration of
glucose (P=0.24), diastolic blood pressure (P=0.11), and smoking
(P=0.97) (Table 2).
Treatment of Dyslipidemia
Out of the 1654 subjects with dyslipidemia 393 (23.8%61.0%;
95%CI: 22.0%, 26.0%) reported to be under treatment of the
disorder. Out of the 393 subjects under treatment, 236 (60.1%)
still had abnormally high levels of total cholesterol or of
triglycerides or abnormally low high-density lipoprotein-choles-
terol concentrations.
Table 1. Associations between the presence of dyslipidemia and other parameters in the Beijing Eye Study 2006.
Univariate analysis:
Parameter P-Value Exponential B 95% Confidence Interval
Age ,0.001 1.02 1.02, 1.03
Female gender 0.001 1.29 1.11, 1.49
Urban region ,0.001 2.09 1.81, 2.43
Body mass index ,0.001 1.11 1.08, 1.13
Body height 0.02 0.99 0.98, 0.99
Body weight ,0.001 1.02 1.02, 1.03
Level of education ,0.001 1.15 1.08, 1.23
Income ,0.001 1.20 1.15, 1.24
Fasting serum concentration glucose concentration ,0.001 1.14 1.08, 1.20
Systolic blood pressure 0.02 1.01 1.01, 1.02
Mean arterial blood pressure 0.03 1.01 1.01, 1.02
Consumption of wine 0.001 0.86 0.78, 0.94
Smoking 0.002 0.79 0.67, 0.92
Consumption of beer 0.79
Binary regression analysis:
Parameter P-Value Exponential B 95% Confidence Interval
Age ,0.001 1.02 1.01, 1.03
Gender ,0.001 1.51 1.25, 1.83
Urban region 0.001 1.82 1.30, 2.55
Body mass index ,0.001 1.13 1.10, 1.15
Income 0.01 1.11 1.02, 1.21
Blood concentr. of glucose ,0.001 1.10 1.05, 1.16
Diastolic blood pressure 0.02 1.02 1.01, 1.03
Smoking 0.04 1.23 1.01, 1.51
Level of education 0.40
Systolic blood pressure 0.56
Consumption of wine 0.24
doi:10.1371/journal.pone.0017326.t001
Dyslipidemia in Rural and Urban China
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17326Discussion
Our study aimed to examine the prevalence of dyslipidemia, its
associated factors, awareness, treatment, and control in the urban
and rural region of Greater Beijing. It revealed that the prevalence
of dyslipidemia was about 56%. Transferred onto the total
population of China, this figure may imply that approximately 175
million Chinese may be affected by dyslipidemia. It shows the
tremendous importance, dyslipidemia may get in the next future in
China.
The results of our study agree with previous populations-based
studies from China. If the results of our study were compared with
the findings from the InterAsia Collaborative Study [15], the mean
concentrations of total cholesterol (4.92 mmol/L or 190.2 mg/dL
versus 186.1 mg/dL), HDL cholesterol (1.61 mmol/L or
62.3 mg/dL versus 51.7 mg/dL), LDL cholesterol (2.88 mmol/L
or 111.4 mg/dL versus 109.5 mg/dL), and triyglcerides
(1.76 mmol/L or 155.3 mg/dL versus 128.1 mg/dL) did not vary
markedly between both studies [15]. Also other regional studies
have previously examined serum lipid concentrations in Chinese
populations [14,23]. The PRC-USA Collaborative Study in
Cardiovascular and Cardiopulmonary Epidemiology, which was
performed in 1983 to 1984, reported that age-adjusted mean
serum total cholesterol level was higher in urban than in rural
samples and generally higher in Beijing than in Guangzhou [23].
In a repeated survey conducted in the same populations during
1993 to 1994, the mean total cholesterol level increased in
Guangzhou but decreased in Beijing [14]. However, this study was
conducted in an occupational population sample of convenience
rather than in a representative sample of the general population. A
rapid increase in total serum cholesterol level has also been
observed in residents living in Shanghai, China [24]. The
differences in dietary nutrient intake between north and south as
well as between rural and urban China may contribute to the
observed regional differences in serum lipid levels [25]. It is
confirmed in our study, in which the prevalence of dyslipidemia
was significantly higher in the urban region than in the rural
region, after adjustment for age, gender, body mass index, income,
blood glucose concentration, diastolic blood pressure and smoking.
It is in agreement with the general increase in the prevalence of
dyslipidemia in China with increasing urbanization and change in
lifestyle. Correspondingly, in the regions with fast economic
growth, such as Guangzhou and Shanghai, the mean level of
serum cholesterol previously increased markedly [14,24]. To
mention an example, over a 10-year period the serum total
cholesterol level for men and women in Guangzhou increased
13.9% and 21.5% in urban areas and 18.9% and 24.9% in rural
areas, respectively [14].
The prevalence of dyslipidemia as found in our study (total
dyslipidemia: 56.160.9%; dyslipidemia without taking into
account history of dyslipidemia: 45.160.9%) and the prevalence
of hypercholesterolemia (19.060.7%), hypertrigylceridemia
(35.560.9%) and hypo HDL-cholesterol (1.760.2%) was partially
comparable to figures reported in previous investigations. To cite
an example, in the InterAsia Collaborative Study, a cross-sectional
survey in a nationally representative sample of 15,540 Chinese
adults 35 to 74 years of age, 23.8% of the subjects had borderline
high total cholesterol (200 to 239 mg/dL), and 9.0% had high
total cholesterol ($240 mg/dL). The population estimates for
borderline high (130 to 159 mg/dL), high (160 to 189 mg/dL),
and very high $190 mg/dL) LDL- cholesterol were 17.0%, 5.1%,
and 2.7%, respectively. In addition, 19.2%, had a low HDL-
cholesterol (,40 mg/dL). In a recent study on 19,003 suburban
Beijing residents aged 18 to 76 years, the age-standardized
prevalence of dyslipidemia was 30.3% [26].
Our findings may have public health implications. Tradition-
ally, mortality from coronary heart disease in China was
infrequent and was estimated to be only 10% of that in Western
populations [22]. A low serum total cholesterol level related to a
low habitual dietary intake of fat and cholesterol was considered to
be the main underlying reason for the low coronary heart disease
mortality in China [23]. In the recent InterASIA study [15], a
relatively high mean level of serum cholesterol but a low rate of
hypercholesterolemia control was noted. These findings were
confirmed by our study which was conducted 5 years after the
InterASIA study. It might explain the recent rapid increase in
coronary heart disease mortality in China. Furthermore, the
findings from the InterASIA study as well as our results suggest
that without a national emphasis on prevention, treatment, and
control of dyslipidemia, the societal burden of cardiovascular
diseases in China will continue to increase in the near future.
Factors associated with dyslipidemia in our study were higher
age, female gender, urban region, higher body mass index,
income, blood concentration of glucose and diastolic blood
pressure, and smoking. In contrast, the level of education, systolic
blood pressure and alcohol consumption were not related with
dyslipidemia. The association between dyslipidemia and higher
age agrees with all previous population-based and hospital-based
studies on the same topic [2,5–23]. In a similar manner, the
previous studies as our study reported on relationships between
dyslipidemia and female gender, urban region, higher body mass
index, income, blood concentration of glucose and diastolic blood
pressure, and smoking. It may suggest that the factors leading to
dyslipidemia and the consequences of dyslipidemia (such as
increased body mass index) are similar across ethnic borders. It
may imply that, as already pointed out above, the increasing rate
of dyslipidemia in China may lead to similar cardiovascular and
cerebrovascular consequences as it did in Western countries
several decades ago.
Table 2. Associations between the awareness of dyslipidemia
and other parameters in the Beijing Eye Study 2006.
Univariate analysis:
Age ,0.001 1.04 1.03, 1.05
Male gender 0.001 0.72 0.59, 0.88
Urban region ,0.001 10.1 7.96, 12.8
Body mass index 0.001 0.96 0.93, 0.98
Income ,0.001 1.67 1.58, 1.77
Blood conc. of glucose 0.02 0.94 0.89, 0.99
Diastolic blood pressure ,0.001 0.94 0.92, 0.95
Smoking ,0.001 0.67 0.54, 0.84
Binary regression analysis:
Urban region 0.001 6.50 4.10, 10.3
Body mass index 0.001 1.06 1.02, 1.09
Income 0.02 1.14 1.02, 1.27
Age 0.56
Gender 0.21
Blood conc. Glucose 0.24
Diastolic blood pressure 0.11
Smoking 0.97
doi:10.1371/journal.pone.0017326.t002
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the present investigation was 50.9%, which was unexpectedly
high. In previous studies from China such as the InterASIA study,
the awareness rate was less than 10%. The reason for the
unexpectedly high awareness rate may be differences in the
regions included into the studies. The average income in the urban
regions included into the Beijing Study was considerably higher
than in other urban regions of Beijing (1688 RMB (Yuan) versus
866 RMB). In addition, the health care system in the urban study
regions which also included quarters with government employees
was better developed than in other urban regions of Beijing. In
parts of the urban study regions, there was a relatively high
standard with some communities supplying free health care
examinations, and in these areas, the cost for medical care was
covered by the government. Correspondingly, the rate of
awareness of dyslipidemia was significantly associated with living
in the urban region. Without doubt, the relatively high income
level and the relatively well developed health care system in the
urban regions of the present study may have artificially increased
the awareness rate of dyslipidemia in our study. In a similar
manner, the rural regions included in our study had a better
developed health care system than other rural regions in the
vicinity so that also the data on the awareness of dyslipidemia from
the rural regions may have a bias and may be artificially high. In
addition, the first survey performed in 2001 included a
questionnaire with questions on the presence, duration and
treatment of dyslipidemia. Although the blood lipids were not
measured in 2001, the questionnaire might have made the study
participants aware of the risks of dyslipidemia, so that they got
their blood examined between 2001 and 2006. It may have led to
a bias with an artificially high rate of awareness of dyslipidemia in
the survey of 2006. The data on the awareness of dyslipidemia as
found in the present study may, therefore, not be representative for
the whole country.
Potential limitations of our study should be mentioned. First, a
major concern in any prevalence study is non-participation. In the
present study, out of 5324 eligible individuals, 4439 subjects
participated in the examination in the year 2001. Out of these
4439 subjects, 3251 (73.2%) returned for the follow-up examina-
tion in the year 2006 in which the blood pressure measurements
were performed. Based on the originally eligible number of 5324
individuals from the year 2001, the number of 3251 participants in
the survey of 2006 indicates a participation rate of 61.1%. The
participants of the survey 2006 compared with the non-
participants of the survey 2006 were significantly younger, came
more often from the rural region, and had a higher level of
education. They did not, however, vary in significantly income
and gender. One may, therefore, infer that the participation rate
may still be acceptable to draw conclusions about the prevalence
and associated factors of dyslipidemia in the Greater Beijing area.
Second, another limitation of the study may be the question how
representative the rural region and the urban regions of Greater
Beijing are for the remaining provinces of China. The unexpect-
edly high rate of awareness of dyslipidemia particularly in the
urban region may suggest that one may be cautious in transferring
the data of awareness of the diseases to other less developed
regions in China. This may, however, not account for the
prevalence of dyslipidemia and its associated factors.
In conclusion, dyslipidemia was present in about 56% of the
study population (aged 45+ years) in Greater Beijing. Factors,
which were likely associated with dyslipidemia, were higher age,
female gender, urban region, higher body mass index, higher
income, higher blood concentration of glucose, higher diastolic
blood pressure, and smoking. In the examined study population,
the treatment rate of dyslipidemia was 24% with about 60% of the
treated subjects still having uncontrolled dyslipidemia.
Methods
Study Participants
The Medical Ethics Committee of the Beijing Tongren Hospital
approved the study protocol and all participants gave written
informed consent. The eligibility criterion for the study was an age
of 40 or more years. The Beijing Eye Study is a population-based
study performed in the region of Greater Beijing. The study was
carried out in 7 communities. Three of the communities were
located in the Daxing District in the village area of Yufa situated
south of Beijing area about 50 to 100 km from the center of
Beijing. Four communities were located in the Haidian urban
district of the Northern part of Central Beijing. The reason to
perform the study in a rural area and in an urban area was that
both areas differed markedly in the level of education, access to
medical care, mobility, frequency of hereditable diseases, and way
of life. In the rural areas, health care services and a referral system
to ophthalmologists were often not available, and the cost for
medical care was usually not covered by the government. In the
urban areas, health care was at a relatively high standard with
some communities supplying free ophthalmic examinations, and in
these areas, the cost for medical care were covered by the
government.
All people residing in the communities were officially registered
by name, gender and age at the local mayor’s office. Using this
register as the sampling frame, all subjects living in the 7
communities and fulfilling the inclusion criterion of an age of 40+
years were eligible for the study. Home visits were performed
according to the registration list, and the eligibility criteria for the
study, an age of 40 or more years, was confirmed by door-to-door
enrollment. Out of 5324 eligible individuals, 4439 individuals
(2505 women) participated (response rate: 83.4%). The mean age
was 56.2610.6 years (range: 40–101 years). The study was
described in detail recently [27–29]. To assess the public health
impact and to address how representative the sample of the study
was for the total population of China, the demographic data of the
study population was compared with census data available for the
population of China and of Beijing [30]. The average monthly
income per capita in the rural areas of Beijing was similar in the
.census (391 RMB (Yuan)) and in the rural part of the study
population (393 RMB (Yuan)). The income figures of the urban
regions were higher in the Beijing Eye Study population (1688
RMB (Yuan)) than in the census (866 RMB (Yuan)). We repeated
the study in the year 2006 by re-inviting all participants from the
previous survey, and 3251 subjects (1838 (56.5%) women)
participated (response rate: 73.2%; 1500 (46.1%) subjects from
the rural region). The mean age was 60.4610.0 years (range: 45–
89 years). For the present study, only data measured in the survey
of 2006 were taken, and only subjects with blood pressure
measurements were considered.
Methods
All examinations were carried out in the communities, either in
schoolhouses or in community houses. Trained research techni-
cians asked the study participants questions from a standard
questionnaire providing information on demographic variables
such as age, gender, level of education, occupation, family income,
known diagnosis of dyslipidemia, and current treatment of
dyslipidemia. In the year 2006, blood samples were additionally
taken. The serum concentrations of total cholesterol, triglycerides,
high-density lipoprotein-cholesterol (HDL-C) and low-density
Dyslipidemia in Rural and Urban China
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matic method with a Hitachi 7600 auto-analyzer (Hitachi, Tokyo,
Japan). Reagents of the same batch were used. Dyslipidemia was
defined as any of hypercholesterolemia (total cholesterol concen-
tration $5.72 mmol/L (220 mg/dL)) or hypertriglyceridemia
(triglyceride concentration $1.70 mmol/L (150 mg/dL)) or low
high-density lipoprotein-cholesterol (HDL-C concentration
#0.91 mmol/L (35 mg/dL)) [31]. Total prevalence of dyslipide-
mia was defined dyslipidemia and / or a positive history for
dyslipidemia. For the statistical analyses, the total prevalence of
dyslipidemia (abnormal blood examinations results and / or
positive history for dyslipidemia) was taken.
Body weight and height and the arterial blood pressure
were also measured
Awareness of dyslipidemia was defined as self-report of any
previous diagnosis of dyslipidemia by a healthcare professional.
Treatment of dyslipidemia was defined as the use of a
pharmacological treatment to lower blood lipids during the
previous 2 weeks. Participants were considered to have controlled
dyslipidemia if their total cholesterol concentration was 5.2 mmol/
l( ,200 mg/dL), or to have controlled LDL cholesterol concen-
tration if their LDL cholesterol was ,3.38 mmol/L (130 mg/mL)
[15].
Statistical Analysis
Inclusion criterion for the present study was the availability of
serum measurements of total cholesterol, triglycerides, and HDL-
C measurements. The statistical analysis was performed using a
commercially available statistical software package (SPSS for
Windows, version 17.0, SPSS, Chicago, IL). The data were given
as mean 6 standard deviation. Logistic regression was used to
investigate the associations of the binary dependent variable
‘‘presence of dyslipidemia’’ with the continuous or categorical
independent variables, such as age, gender, area, body mass index,
the concentrations of glucose, blood pressure, education and
income. Confidence intervals were presented. All P-values were
two-sided and were considered statistically significant when the P-
values were less than 0.05. Based on the data of the 2000 China
population census, the mean data and the prevalences were
adjusted to calculate the total number of subjects with dyslipide-
mia in China [32].
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